Open AccessTHE EFFICIENCY AND COST OF LOCAL HYPOTENSIVE THERAPY IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA IN CIS
Author(s) -
A.V. Kuroyedov,
Л. Д. Абышева,
R. V. Avdeyev,
A. S. Alexandrov,
A. S. Basinsky,
E. A. Blyum,
A. Yu. Brezhnev,
И. Р. Газизова,
А. Б. Галимова,
О. В. Гапонько,
V. V. Garkavenko,
А. М. Гетманова,
В. В. Городничий,
М. С. Горшкова,
A. A. Gusarevitch,
S. V. Diordiychuk,
D. A. Dorofeyev,
С. А. Жаворонков,
P. Ch. Zavadsky,
А. Б. Захидов,
О. Г. Зверева,
У. Р. Каримов,
Anita Kulik,
С. Н. Ланин,
Дж. Н. Ловпаче,
И. А. Лоскутов,
Е. В. Молчанова,
Н. А. Нефедов,
V. Yu. Ogorodnikova,
O. N. Onufrichuk,
S. Yu. Petrov,
Yu. I. Rozhko,
Т. А. Сиденко,
Л. Б. Таштитова,
М. С. Худжатова
Publication year - 2015
Publication title -
problemy zdorovʹâ i èkologii
Language(s) - English
Resource type - Journals
eISSN - 2708-6011
pISSN - 2220-0967
DOI - 10.51523/2708-6011.2015-12-1-6
Subject(s) - glaucoma , open angle glaucoma , medicine , intraocular pressure , ophthalmology , cost effectiveness , combination therapy , risk analysis (engineering)
Objective: to determine the efficiency of the treatment for glaucoma and its accompanying costs in patients with II-III stages of open-angle glaucoma. Material and methods. The multicenter study which was conducted by 35 investigators in 29 clinical centers in 4 CIS countries from December 2013 to April 2014 took into account the results of the treatment of 115 patients (187 eyes) with glaucoma. The cost and «cost-effectiveness» of the intraocular pressure (IOP)-lowering treatment were calculated with the account of IOP-level compensation. Results. The average cost-effectiveness was 13.94 ± 0.66 rubles/day, which was comparable to the theoretical cost of the treatment but 32 % exceeded the price that patients actually paid for the treatment. As for the monotherapy with prostaglandin preparations and the fixed combination of beta-adrenoblocker and prostaglandin analogue (BB + PG), the difference between the actual price and cost-effectiveness was 44 %. At the same time, this difference in the application of the fixed combination of beta-adrenoblocker and carbonic anhydrase inhibitor (BB + CAI) made up 64 %. Conclusion. It is cheaper to achieve a controlled IOP level in the application of the fixed combination BB + PG compared to the BB + CAI fixed combination treatment.